Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum

Neuroscience

Volumn 85, Issue 2, 1998, Pages 395-403

  Szabo, B ^a   Dorner L ^a   Pfreundtner, C ^a   Norenberg W ^a   Starke, K ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Calcium channel; Cannabinoid receptor; Corpus striatum; Inhibitory postsynaptic current; Medium spiny neuron; Presynaptic inhibition

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 AMINOBUTYRIC ACID; [2,3 DIHYDRO 5 METHYL 3 [(MORPHOLINYL)METHYL]PYRROLO[1,2,3 DE] 1,4 BENZOXAZIN YL](1 NAPHTHALENYL)METHANONE; CALCIUM; CANNABINOID; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CARBACHOL; MESSENGER RNA; MUSCARINIC RECEPTOR; MUSCIMOL; RIMONABANT; UNCLASSIFIED DRUG;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL TISSUE; ARTICLE; BINDING SITE; CALCIUM CURRENT; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; FEMALE; MALE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT;

ANIMALS; CANNABINOIDS; CORPUS STRIATUM; ELECTRIC STIMULATION; FEMALE; GABA AGENTS; MALE; MEMBRANE POTENTIALS; NEURAL INHIBITION; NEURONS; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR; SYNAPSES;

EID: 0032495836     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00597-6     Document Type: Article

References (51)

1. Abood M. E., Martin B. R. Neurobiology of marijuana abuse. Trends pharmac. Sci. 13:1992;201-206.
2. 2+ currents in acutely isolated, adult rat neostriatal neurons. J. Neurosci. 14:1994;6667-6686.
3. Caulfield M. P., Brown D. A. Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a Pertussis toxin-sensitive mechanism. Br. J. Pharmac. 106:1992;231-232.
4. Childers S. R., Deadwyler S. A. Role of cyclic AMP in the actions of cannabinoid receptors. Biochem. Pharmac. 52:1996;819-827.
5. Deadwyler S. A., Hampson R. E., Mu J., Whyte A., Childers S. Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. J. Pharmac. exp. Ther. 273:1995;734-743.
6. Edwards F. A. and Konnerth A. (1992) Patch-clamping cells in sliced tissue preparations. In Methods in Enzymology (eds Rudy B. and Iverson L. E.), Vol. 207, pp. 208-222. Academic, San Diego.
7. Fan P. Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons. J. Neurophysiol. 73:1995;907-910.
8. Felder C. C., Joyce K. E., Briley E. M., Mansouri J., Mackie K., Blond O., Lai Y., Ma A. L., Mitchell R. L. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Molec. Pharmac. 48:1995;443-450.
9. Gifford A. N., Ashby C. R. Jr. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. J. Pharmac. exp. Ther. 277:1996;1431-1436.
10. Glass M., Dragunow M., Faull R. L. M. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiography study in the fetal, neonatal and adult human brain. Neuroscience. 77:1997;299-318.
11. Götz T., Kraushaar U., Geiger J., Lübke J., Berger T., Jonas P. Functional properties of AMPA and NMDA receptors expressed in identified types of basal ganglia neurons. J. Neurosci. 17:1997;204-215.
12. Heimer L., Zahm D. S. and Alheid G. F. (1995) Basal ganglia. In The Rat Nervous System (ed. Paxinos G.), pp. 579-628. Academic, San Diego.
13. Henry D. J., Chavkin C. Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci. Lett. 186:1995;91-94.
14. Herkenham M., Lynn A. B., De Costa B. R., Richfield E. K. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 547:1991;267-274.
15. Howe A. R., Surmeier D. J. Muscarinic receptors modulate N-, P-, and L-type Ca2+ currents in rat striatal neurons through parallel pathways. J. Neurosci. 15:1995;458-469.
16. Howlett A. C. Pharmacology of cannabinoid receptors. A. Rev. Pharmac. Toxicol. 35:1995;607-634.
17. Ishac E. J. N., Jiang L., Lake K. D., Varga K., Abood M. E., Kunos G. Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br. J. Pharmac. 118:1996;2023-2028.
18. Jansen E. M., Haycock D. A., Ward S. J., Seybold V. S. Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles. Brain Res. 575:1992;93-102.
19. Jiang Z.-G., North R. A. Membrane properties and synaptic responses of rat striatal neurones in vitro. J. Physiol. 443:1991;533-553.
20. Jung M., Calassi R., Rinaldi-Carmona M., Chardenot P., Le Fur G., Soubrie P., Oury-Donat F. Characterization of CB1 receptors on rat neuronal cell cultures: binding and functional studies using the selective receptor antagonist SR 141716A. J. Neurochem. 68:1997;402-409.
21. Kangrga I. M., Loewy A. D. Whole-cell patch-clamp recordings from visualized bulbospinal neurons in the brainstem slices. Brain Res. 641:1994;181-190.
22. Kawaguchi Y., Wilson C. J., Augood S. J., Emson P. C. Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci. 18:1995;527-535.
23. Llano L., Marty A., Armstrong C. M., Konnerth A. Synaptic- and agonist-induced excitatory currents of Purkinje cells in rat cerebellar slices. J. Physiol. 434:1991;183-213.
24. Mackie K., Devane W. A., Hille B. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N 18 neuroblastoma cells. Molec. Pharmac. 44:1993;498-503.
25. Mackie K., Hille B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. natn. Acad. Sci. U.S.A. 89:1992;3825-3829.
26. Mackie K., Lai Y., Westenbroek R., Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J. Neurosci. 15:1995;6552-6561.
27. Mailleux P., Vanderhaeghen J.-J. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience. 48:1992;655-668.
28. Maneuf Y. P., Crossman A. R., Brotchie J. M. Modulation of GABAergic transmission in the globus pallidus by the synthetic cannabinoid WIN 55,212-2. Synapse. 22:1996;382-385.
29. Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. C., Bonner T. I. Structure of cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
30. McLaughlin C. R., Abood M. E. Developmental expression of cannabinoid receptor mRNA. Devl Brain Res. 76:1993;75-78.
31. Miller A. S., Walker M. J. Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata. Eur. J. Pharmac. 279:1995;179-185.
32. Miller A. S., Walker M. J. Electrophysiological effects of a cannabinoid on neural activity in the globus pallidus. Eur. J. Pharmac. 304:1996;29-35.
33. Mintz I. M., Sabatini B. L., Regehr W. G. Calcium control of transmitter release at a cerebellar synapse. Neuron. 15:1995;675-688.
34. Munro S., Thomas K. L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:1993;61-65.
35. Nörenberg W., Wirkner K., Illes P. The effect of adenosine and some of its structural analogues on the conductance of NMDA receptor channels in a subset of rat neostriatal neurones. Br. J. Pharmac. 122:1997;71-80.
36. 2+ channels in a neuronal expression system. J. Pharmac. exp. Ther. 49:1996;707-714.
37. Park M. R., Lighthall J. W., Kitai S. T. Recurrent inhibition in the rat neostriatum. Brain Res. 194:1980;359-369.
38. Penner R. (1992) Measurement of cell membrane capacitance. In Practical Electrophysiological Methods (eds Kettenmann H. and Grantyn R.), pp. 358-362. Wiley-Liss, New York.
39. 2 receptors. Pharmac. Ther. 74:1997;129-180.
40. Pertwee R. G., Fernando S. R. Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder. Br. J. Pharmac. 118:1996;2053-2058.
41. Pertwee R. G., Stevenson L. A., Elrick D. B., Mechoulam R., Corbett A. D. Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br. J. Pharmac. 105:1992;980-984.
42. Rinaldi-Carmona M., Barth F., Héaulme M., Alonso R., Shire D., Congy C., Soubrié P., Brelière J.-C., Le Fur G. Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci. 56:1995;1941-1947.
43. Schlicker E., Timm J., Göthert M. Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn-Schmiedeberg's Arch. Pharmac. 354:1996;791-795.
44. Schlicker E., Timm J., Zentner J., Göthert M. Cannabinoid-CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Naunyn-Schmiedeberg's Arch. Pharmac. 356:1997;583-589.
45. Shen M., Piser T. M., Seybold V. S., Thayer S. A. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J. Neurosci. 16:1996;4322-4334.
46. Showalter V. M., Compton D. R., Martin B. R., Abood M. E. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identification of cannabinoid receptor subtype selective ligands. J. Pharmac. exp. Ther. 278:1996;989-999.
47. Sim L. J., Hampson R. E., Deadwyler S. A., Childers S. R. Effects of chronic treatment with delta-9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTP-gamma-S autoradiography in rat brain. J. Neurosci. 16:1996;8057-8066.
48. Stuart G. J., Dodt H.-U., Sakmann B. Patch-clamp recordings from the soma and dendrites of neurons in brain slices using infrared video microscopy. Pflügers Arch. 423:1993;511-518.
49. Sugita S., Uchimura N., Jiang Z.-G., North R. A. Distinct muscarinic receptors inhibit release of gamma-aminobutyric acid and excitatory amino acids in mammalian brain. Proc. natn. Acad. Sci. U.S.A. 88:1991;2608-2611.
50. Tersigni T. J., Rosenberg H. C. Local pressure application of cannabinoid agonists increases spontaneous activity of rat substantia nigra pars reticulata neurons without affecting response to iontophoretically-applied GABA. Brain Res. 733:1996;184-192.
51. Westlake T. M., Howlett A. C., Bonner T. I., Matsuda L. A., Herkenham M. Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Neuroscience. 63:1994;637-652.